Found 207 matching trials
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
PHASE2Researchers conducting this study hope to learn about the safety and effect...
Location
University of Chicago Comprehensive Cancer Center
Neoadjuvant Letrozole in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative, Node Positive, Early-Stage Breast Cancer.
PHASE2The goal of this clinical trial is to learn whether letrozole, a hormone th...
Location
Cancer Care Hospital and Research Centre Foundation
Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy
PHASE2This study is to measure the extent of tumor shrinkage when Letrozole and Z...
Location
Novartis Investigative Site
Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients
PHASE2A multicenter, prospective, open, randomized cohort, non controlled phase I...
ETHAN - ET for Male BC
PHASE2This research study is looking to see how well male breast cancer responds ...
Location
Georgetown University Medical Center
Neoadjuvant Treatment of Breast Cancer
N/AObservational investigation of participants who are given neoadjuvant treat...
Location
National Institute of Oncolgy
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer
PHASE2The purpose of this study is to find out whether combining a shorter than s...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
PHASE3RATIONALE: Hormones can stimulate the growth of prostate cancer cells. Horm...
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer
PHASE2The purpose of this trial is to evaluate efficacy and toxicity of either th...
Status
Active Not Recruiting
Location
Dept. of Oncology, Ărebro University Hospital
Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer
PHASE2This is an open-label, multicenter international trial in men and women wit...
Status
Active Not Recruiting
Location
Sainte Catherine - Institut du Cancer Avignon Provence